PBSC PREGNANCY D-HPLC BCR-ABL1 BONE MARROW TRANSPLANTATION BCR-ABL MUTATIONS CHILDREN AND ADOLESCENTS BCR/ABL GENE DASATINIB ENACT CHRONIC MYELOID LEUKAEMIA CHRONIC MYELOID LEUKEMIA DASATINIBE GENERIC IMATINIB PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION LOW EDUCATION LEVEL EDI-PIO GENE SEPT5 ALLOGENEIC BONE MARROW 2022 PEDIATRIC PATIENTS TKI BCR/ABL NILOTINIB HOCT1 IMATINIB ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION STEM CELL TRANSPLANTATION FIRST LINE TERAPHY TYROSINE KINASE INHIBITORS CARDIOVASCULAR EVENTS CYTOGENETIC REMISSION CHRONIC PHASE BCR-ABL CARDIOVASCULAR NILOTINIBE WHO CARDIOVASCULAR RISK MULTICENTER STUDY SARS-COV-2 COMORBIDITIES DISCONTINUATION TRIAL HMGCLL1 THIRD-LINE TKI TREATMENT PATIENTS IN BRAZIL BRAZIL F359V SURVIVAL NON-MYELOABLATIVE PIOGLITAZONE TFR